ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Anti-Her2 affibody-decorated arsenene nanosheets induce ferroptosis through depleting intracellular GSH to overcome cisplatin resistance

He, Peng; Xu, Shenglin; Miao, Zhaohua; Que, Yukang; Chen, Yu; Li, Sheng; Ma, Qiming; Yang, Rui; Wei, Wei*; Zha, Zhengbao*; Hu, Yong*安徽医科大学; 1; y
JOURNAL OF NANOBIOTECHNOLOGY2023-6-27DOI: 10.1186/s12951-023-01963-7
4被引3阅读
引用收藏
分享

摘要

Ferroptosis, a form of regulated cell death induced by excessive accumulation of reactive oxygen species and lipid peroxidation, has recently attracted extensive attention due to its ability to effectively suppress tumors and overcome drug resistance. Unlike previously reported metal nanomaterials that induce ferroptosis via the Fenton reaction, arsenene nanosheets can effectively deplete intracellular glutathione and then induce ferroptosis by inhibiting glutathione peroxidase 4. In this study, we designed target-modified arsenene nanosheets loaded with cisplatin (Her2-ANs@ CDDP), which are capable of selective uptake by tumor cells. Her2-ANs@CDDP promotes both apoptosis and ferroptosis through a reciprocal cascade reaction between cisplatin and the carrier, respectively, and we demonstrate that it can significantly inhibit the activity of drug-resistant cells. Arsenene nanosheets kill drug-resistant tumor cells by inducing ferroptosis and restoring the sensitivity of drug-resistant cells to cisplatin. Cisplatin-loaded arsenene nanosheets can be prepared simply, and exert synergistic effects that overcome drug resistance. They show great potential for applications in the clinical treatment of chemotherapy-insensitive osteosarcoma, expanding the uses of arsenic in the treatment of solid tumors. @@@ [GRAPHICS]

学科与关键词

关键词
FerroptosisArsenene nanosheetsChemotherapyCisplatin resistanceOsteosarcoma
相关
加载中…
  • PSMA-targeted arsenic nanosheets: a platform for prostate cancer therapy via ferroptosis and ATM deficiency-triggered chemosensitization
    Wang, Hui; Zhang, Li; Miao, Zhaohua; Zhang, Meng; Liu, Hang; He, Qiong; Meng, Jialin; Wen, Longping; Ke, Zunfu; Zha, Zhengbao*; Lin, Run*; Liang, Chaozhao*Materials Horizons, 2021, 8(8): 2216-2229.被引 12
  • Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer Treatment
    Wang, Youke; Yuan, Xiang; Ren, Min*; Wang, Zhiyu*AMERICAN JOURNAL OF CHINESE MEDICINE, 2024.
  • Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies
    Wang, Lina; Liu, Zejun; He, Shumei; He, Shasha; Wang, Yupeng*Journal of Materials Chemistry B, 2021, 9(22): 4587-4595.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF NANOBIOTECHNOLOGY
发表日期
2023-06-27
卷期
第 21 卷, 第 1 期
页码
203
DOI
10.1186/s12951-023-01963-7
语言
ENGLISH
成果收录
SCIE
资助标注
Major Project of Natural Science Foundation of Anhui Province Colleges and Universities [KJ2020ZD17]; Basic and Clinical Cooperative Research Project of Anhui Medical University [2020xkjT033]; Open Fund Project of the Key Laboratory of Anti-inflammatory and Immunological Drugs Ministry of Education [KFJJ-2020-04]

作者

  • H

    He, Peng (第一作者)

    1 · anhui med univ

  • X

    Xu, Shenglin

    1 · anhui med univ

查看全部 11 位作者收起作者
  • M

    Miao, Zhaohua

  • Q

    Que, Yukang

    1 · anhui med univ

  • C

    Chen, Yu

  • L

    Li, Sheng

    1 · anhui med univ

  • M

    Ma, Qiming

    1 · anhui med univ

  • Y

    Yang, Rui

    1 · anhui med univ

  • W

    Wei, Wei (通讯)

    anhui med univ

  • Z

    Zha, Zhengbao (通讯)

  • H

    Hu, Yong (通讯)

    1 · anhui med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417